Ventricular repolarization time indexes following anthracycline treatment

Area of Science:

• Cardiology
• Oncology
• Pharmacology

Background:

• Anthracyclines like doxorubicin are vital chemotherapy agents but can cause fatal cardiotoxicity.
• Current cardiac monitoring methods like ECG and echocardiograms lack consistent predictive value for cardiotoxicity.
• Identifying high-risk patients before cardiac damage is crucial for clinical management.

Purpose of the Study:

• To evaluate the impact of doxorubicin on ventricular repolarization time indexes.
• To determine if these indexes can serve as early markers for doxorubicin-induced cardiotoxicity.
• To assess the relationship between doxorubicin treatment and electrical myocardial instability.

Main Methods:

• Electrocardiograms (ECG) were analyzed in 35 cancer patients.
• ECGs were compared between the initial drug-free state and after doxorubicin treatment (29.4 +/- 37.65 weeks).
• Ventricular repolarization time indexes, including QTc, JT, and JTc dispersion, were assessed.

Main Results:

• Doxorubicin treatment led to a significant increase in ventricular recovery time dispersion indexes (QTc, JT, JTc).
• These changes occurred even after a short treatment period.
• Echocardiographic parameters did not show significant modification concurrently.

Conclusions:

• Increased regional variation in ventricular repolarization may indicate early cardiotoxicity from doxorubicin.
• This electropathy, identified by dispersion indexes, could be an early warning sign for heart failure.
• Ventricular repolarization dispersion shows potential as an early, noninvasive marker for doxorubicin cardiotoxicity.